96 results
Page 2 of 5
8-K
EX-99.1
w74su u6fhyu
4 May 21
Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume in First Quarter of 2021
4:07pm
8-K
EX-4.1
57xw ftr2
8 Apr 21
Entry into a Material Definitive Agreement
4:29pm
8-K
EX-10.1
9l8v8dq19 jl0vpu0
5 Apr 21
Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives
4:13pm
8-K
EX-1.1
suve0
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
3xw90jv4u i96kirw
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
3aelhx g85
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
tswb41pd 3h7
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
lnjn5xd8asf188wfn
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-10.3
zkmq05ow1fa8oj 1l
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
5lgw8yg3vu3n9
28 Aug 20
Prospectus supplement
4:31pm
425
tqbrjjae g4o1y6d
24 Jun 20
Business combination disclosure
5:11pm